Acne Scars Are Four Different Problems, and Only One of Them Is a Laser Problem

There is a conversation that happens thousands of times a week in dermatology and plastic surgery offices. A patient in their twenties or thirties sits down, points at their cheeks and temples, and says the acne cleared years ago but the texture never did. The provider looks at the skin under a good light and recommends a course of fractional laser resurfacing. Three or four sessions, several thousand dollars, a week of downtime each time.

Sometimes that is exactly right. Frequently it is not, and the reason has nothing to do with the device being bad. It is that acne scarring is not a single condition with a single correct treatment. It is a category containing at least four anatomically distinct problems that happen to share a cause. One of them lives in the surface of the skin, which is where a resurfacing device works. The others live below it, in tethering bands, in narrow tracts running down into the dermis, or in raised collagen that is the opposite problem entirely. Pointing an ablative device at a scar whose mechanism sits three millimeters underneath the treated layer produces a modest, expensive, temporary improvement and a patient who concludes that nothing works.

The distinction is not obscure or contested. It has been in the dermatologic literature since the beginning of this century, it is taught, and the practitioners who work in this area seriously use it every day. It just rarely survives the trip to the consultation room, because the consultation room is frequently selling a device.

Before you treat a scar, confirm it is a scar

The short answer: a large fraction of what patients call acne scarring is discoloration, not scarring, and discoloration resolves on its own timeline without any resurfacing procedure at all.

Two conditions get misfiled as scars constantly. Post-inflammatory erythema is the flat pink or red mark left behind after an inflamed lesion clears, caused by dilated capillaries rather than by lost or excess collagen. Post-inflammatory hyperpigmentation is the flat brown or grey mark caused by pigment released during inflammation, and it is markedly more common and more persistent in deeper skin tones. Neither is a scar. Neither involves a change in the contour of the skin. Both fade, over months to a couple of years, and both are treatable with things considerably less aggressive than an ablative laser: sun protection, topical retinoids, and for pigment specifically, the tyrosinase-inhibiting approaches discussed in what actually works on melasma, where the same overtreatment trap appears in a different disease.

The test is simple and a patient can do it in a mirror. Turn the light so it rakes across the face from the side rather than hitting it straight on. A true scar casts a shadow, because it has depth or elevation. A pigment or vascular mark disappears under side lighting because the surface is flat. Anyone who has looked closely at gallery photographs and wondered why the results look better than the reality has already met the corollary, described in how to read a before-and-after gallery: change the lighting angle and you change the apparent severity of every textural problem on a face.

There is a second sorting step. True acne scars split into atrophic scars, where tissue is lost and the skin sits below the surrounding plane, and hypertrophic or keloidal scars, where excess collagen sits above it. Atrophic scarring is the large majority of facial cases. Raised scarring is more common on the chest, back, shoulders, and along the jawline, and more common in patients with deeper skin tones. The treatments run in opposite directions. Atrophic scars are treated by adding volume or releasing tissue. Raised scars are treated by suppressing collagen, typically with intralesional corticosteroid injection, sometimes combined with 5-fluorouracil, along with the silicone-based measures covered in what the evidence supports in scar care. Treating one with the tools meant for the other makes things worse in a way that is difficult to undo.

Four shapes, and the shape decides the treatment

The short answer: atrophic acne scars are conventionally divided into icepick, boxcar, and rolling types, first formalized in a 2001 classification in the Journal of the American Academy of Dermatology, and each one fails to respond to at least one of the standard treatments.

The categories are defined by geometry, and the geometry reflects what happened to the tissue.

• Icepick scars. Narrow, generally under two millimeters across, and deep. They descend as a V-shaped tract, sometimes epithelialized along its length, reaching well into the dermis and occasionally to the subcutaneous layer. They are the most common type in most published series, usually cited around sixty to seventy percent of atrophic acne scars.
• Boxcar scars. Round or oval depressions with sharply defined vertical walls and a flat base, typically one and a half to four millimeters wide. They are subdivided by depth. Shallow boxcar scars sit within a few tenths of a millimeter of the surface. Deep boxcar scars extend beyond half a millimeter. That subdivision is not academic, because it is the line between a scar a resurfacing device can level and one it cannot.
• Rolling scars. Wider, generally over four millimeters, with sloping indistinct edges that give the skin an undulating appearance rather than discrete pits. The surface is often close to normal. The problem is underneath: fibrous bands tethering the dermis down to the subcutaneous tissue, pulling the surface into a dip.
• Hypertrophic and keloidal scars, as above, are a separate disease running the other direction.

Most patients have a mix. A cheek can carry rolling scarring across the mid-face, a scatter of icepick scars near the nose, and a handful of deep boxcars along the jaw. This is exactly why a single-device treatment plan underperforms. The plan is being written for the category the device treats, not for the face.

Severity grading is a separate axis. The Goodman and Baron qualitative global acne scarring system, published in 2006, sorts overall severity into four grades running from macular disease visible only at close range through to severe disease evident at social distance. It is a coarse instrument, but it is one of the few standardized scales in this field, and its existence points at the underlying problem with the evidence base. Trials of acne scar treatment are mostly small, mostly short in follow-up, and mostly use non-comparable outcome measures, which makes head-to-head claims between devices far weaker than the marketing around them suggests.

"

A rolling scar is a tethering problem. A laser is a surface tool. Aiming one at the other is not a conservative first step, it is a category error with a price tag and a week of downtime attached.

"

Rolling scars are tethered, and nothing done at the surface reaches a tether

The short answer: rolling scars are treated by cutting the fibrous bands that anchor the dermis down, a procedure called subcision, and no amount of surface resurfacing releases a band sitting below the dermis.

Subcision was described in the dermatologic literature in 1995 as subcutaneous incisionless surgery. The technique is mechanical and unglamorous. A needle or a small blunt cannula is introduced through a puncture in the skin, advanced into the plane between the dermis and the subcutaneous tissue, and swept back and forth to divide the fibrous strands tethering the surface down. Two things then happen. The surface is released and rises toward the surrounding plane, and the controlled injury produces new collagen in the space that has been opened, which contributes additional lift over the following weeks.

Bruising afterward is substantial and expected, often for a week or more. That is the visible sign of the plane having been opened, and it is also the source of the main complication, which is a hematoma or a firm nodule where blood collects and organizes. Multiple sessions are standard, because bands recur and the release is partial. The same mechanical logic, and the same limits, appear in the depressed dimpling addressed in what the evidence says about cellulite treatment, where tethering septae are also the target and where several device companies have built entire product categories around cutting or releasing them.

Subcision is frequently combined with filler or with a biostimulatory agent placed into the released plane to hold the space open while collagen forms. It is also increasingly paired with radiofrequency microneedling in the same visit. What matters for a patient evaluating a plan is whether subcision is in it at all. If the face is predominantly rolling scarring and the proposed course is four sessions of a fractional device with no release step, the plan is treating the roof of a problem that lives in the basement.

Icepick and sharp-walled boxcar scars have to be removed, not sanded

The short answer: a deep narrow tract cannot be resurfaced away, because reaching its base with an ablative device would require destroying the normal skin around it, so these scars are treated by destroying or excising the tract itself.

There are two established approaches, and both are minor surgical procedures rather than device treatments.

The first is focal high-concentration trichloroacetic acid, applied only into the scar tract and not to the surrounding skin. The technique is usually called CROSS, for chemical reconstruction of skin scars. A sharpened wooden applicator or a fine tip is dipped in TCA at a concentration far above what would ever be painted across a full face, generally in the sixty-five to one hundred percent range, and pressed into the opening of the icepick scar. The acid destroys the epithelial lining of the tract and provokes collagen formation that narrows and lifts it from the base upward. Surrounding skin is untouched, which is the entire point. Several sessions are required, spaced weeks apart, and improvement is incremental. The risk is a mishandled application producing a wider mark than the one being treated, and the risk of pigment change is real in deeper skin tones, which sits inside the broader risk pattern laid out in where the actual risk sits with cosmetic procedures on deeper skin tones.

The second is surgical. Punch excision removes the scar with a small circular blade, typically one and a half to three millimeters across, and the resulting defect is closed with a fine suture or a graft taken from behind the ear. The scar is traded for a small linear or round mark that heals to something considerably less noticeable than the pit. Punch elevation is the variant used for deep boxcar scars with sharp walls and an acceptable base: the disc of tissue is cut but not removed, allowed to float up to the level of the surrounding skin, and secured there. The floor of the scar becomes the new surface, so the color and texture match, and only the sharp edges have to heal.

Both approaches are done before, not after, any resurfacing course. The sequence is deliberate. Excise or elevate the discrete lesions first, let them heal for six to twelve weeks, then resurface the whole field to blend the residual texture. Doing it the other way round means paying to resurface skin that is about to be cut out.

What resurfacing and filler actually deliver, and in what order

The short answer: fractional resurfacing and radiofrequency microneedling are genuinely effective on shallow boxcar scarring and generalized texture, filler has exactly one product with a specific FDA indication for acne scars, and no honest plan promises elimination.

Resurfacing devices work by producing controlled columns of thermal injury and letting the surrounding untreated tissue drive healing, the mechanism described in how lasers and peels actually differ. On shallow boxcar scars and on the diffuse roughening that surrounds discrete lesions, that works. Ablative fractional carbon dioxide and erbium devices produce the largest textural change and carry the longest recovery and the highest pigment risk. Non-ablative fractional devices are gentler with less downtime and require more sessions for less change. Radiofrequency microneedling delivers energy through insulated needles at a set depth, largely sparing the epidermis, which is why it has become the more common choice in deeper skin tones. The deep phenol formulations covered in what a deep chemical peel does that nothing else does sit at the far end of the same spectrum and are rarely the answer for a scattered acne scar pattern.

What none of these do is lift a tethered surface or eliminate a tract. Realistic published improvement across the resurfacing literature clusters in the range of a fifty to seventy-five percent reduction in scar appearance over a multi-session course, on selected scar types, graded by clinicians using scales that are not standardized between studies. That is a meaningful result. It is not the result implied by a gallery.

Filler occupies an odd position here. Injectables are widely used for atrophic acne scarring, and nearly all of that use is off-label. One product, a polymethyl methacrylate and collagen filler, holds a specific FDA approval, granted in early 2015, for the correction of moderate to severe atrophic distensible facial acne scars on the cheek in patients over twenty-one. Distensible is the operative word: the scar has to lift when the skin is stretched, which means it is not rigidly tethered. Everything else, hyaluronic acid and biostimulatory products alike, is being used outside its cleared indication, which is legal and often reasonable but should be disclosed. The permanent component in that particular product also means the late nodule question discussed in why filler nodules appear a year later is not a small consideration, and the general principle of asking what a product is actually approved to do is the one set out in what is authorized to go into your skin.

Two sequencing rules govern everything above. Active acne is controlled first, because resurfacing an inflamed face produces new lesions and new scars. And if isotretinoin is part of that control, the timing conversation is more open than the old blanket rule suggests, as covered in what the evidence actually supports about waiting after isotretinoin.

The honest summary

Acne scarring is one of the few areas in aesthetics where the diagnostic step matters more than the technology, and it is routinely skipped. The four categories are not subtle, they can be identified in a mirror with side lighting in about a minute, and they have different answers. Rolling scars need release from below, which means subcision. Icepick scars need the tract destroyed or excised, which means focal high-concentration acid or a punch. Deep boxcar scars need elevation or excision. Shallow boxcar scars and general texture are where resurfacing devices genuinely earn their place. Raised scars are a different disease treated with the opposite intent.

The practical consequence for a patient is that a plan built around a single device is almost always incomplete, and the incompleteness is not disclosed. The most common failure is not a bad laser. It is four sessions of a reasonable laser applied to a face whose dominant problem was tethering, followed by the conclusion that acne scars cannot be treated. They can. The order is what people get wrong: sort the marks from the scars, sort the scars by shape, do the surgical and release work first, resurface the field afterward, and treat pigment last.

Expect improvement, not erasure. A well-sequenced combination course over six to twelve months moves most patients a meaningful distance, and the published numbers and the honest surgeons converge on a similar range. Anyone promising smooth skin from a package of three sessions is describing an outcome that does not appear anywhere in the literature, and the gap between promise and result is the single largest driver of the disappointment pattern described in where satisfaction numbers actually come from.